Mytrex Health Technologies, Inc. (TPEX:4431)
Taiwan · Delayed Price · Currency is TWD 18.75
0.00 (0.00%)
Aug 21, 2026, 1:31 PM CST
TPEX:4431 Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,053 | 1,945 | 1,759 | 1,293 | 1,472 | 291.62 | |
Revenue Growth | 7.43% | 10.59% | 36.02% | -12.14% | 404.61% | -71.51% |
Cost of Revenue | 1,812 | 1,702 | 1,537 | 1,101 | 1,232 | 251.48 |
Gross Profit | 241.19 | 242.58 | 221.55 | 192.35 | 239.4 | 40.14 |
Selling, General & Admin | 300.31 | 305.43 | 337.77 | 294.25 | 310.74 | 53.65 |
Research & Development | 2.93 | 3.57 | 2.86 | 12.3 | 16.4 | 1.98 |
Other Operating Expenses | -39.21 | -41.29 | -42.12 | -43.65 | -40.87 | -0.01 |
Operating Expenses | 256.28 | 267.85 | 299.18 | 264.17 | 286.15 | 55.6 |
Operating Income | -15.08 | -25.27 | -77.63 | -71.83 | -46.74 | -15.46 |
Interest Expense | -3.98 | -5.07 | -6.13 | -6.22 | -5.21 | -1.58 |
Interest & Investment Income | 4.86 | 3.97 | 2.89 | 2.3 | 1.15 | 0.67 |
Earnings From Equity Investments | 1.23 | 1.08 | -0.26 | 0.94 | 1.66 | -0.86 |
Currency Exchange Gain (Loss) | -0.3 | -0.3 | 2.6 | 0.76 | 10.24 | -4.05 |
Other Non Operating Income (Expenses) | 3.02 | -0.32 | 18.26 | 20.05 | 20.9 | 0.15 |
EBT Excluding Unusual Items | -10.26 | -25.9 | -60.27 | -54 | -18.01 | -21.13 |
Gain (Loss) on Sale of Investments | - | - | - | - | -1.06 | 33.34 |
Gain (Loss) on Sale of Assets | -2.77 | -2.77 | 17.51 | -4.1 | 8.68 | -0.16 |
Asset Writedown | -1.26 | -1.26 | -41.65 | 0.92 | -51.47 | -25.65 |
Other Unusual Items | 8.43 | 8.43 | 0.09 | - | - | - |
Pretax Income | -5.85 | -21.5 | -84.32 | -57.18 | -61.86 | -13.6 |
Income Tax Expense | 3.45 | 4.35 | 0.51 | 1.11 | 7.1 | 0.45 |
Earnings From Continuing Operations | -9.3 | -25.85 | -84.83 | -58.29 | -68.96 | -14.05 |
Minority Interest in Earnings | 3.99 | 9.25 | 2.46 | 2.07 | -22.94 | 0.04 |
Net Income | -5.32 | -16.6 | -82.38 | -56.22 | -91.9 | -14.01 |
Net Income to Common | -5.32 | -16.6 | -82.38 | -56.22 | -91.9 | -14.01 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 37 | 37 | 37 | 37 | 37 | 37 |
Shares Outstanding (Diluted) | 37 | 37 | 37 | 37 | 37 | 37 |
Shares Change | 2.55% | - | - | - | 0.00% | 11.05% |
EPS (Basic) | -0.14 | -0.45 | -2.25 | -1.54 | -2.52 | -0.38 |
EPS (Diluted) | -0.14 | -0.45 | -2.25 | -1.54 | -2.52 | -0.38 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 218.06 | 196.17 | 22.75 | -26.03 | 36.98 | -16.46 |
Free Cash Flow Per Share | 5.86 | 5.37 | 0.62 | -0.71 | 1.01 | -0.45 |
Gross Margin | 11.75% | 12.47% | 12.60% | 14.88% | 16.27% | 13.76% |
Operating Margin | -0.73% | -1.30% | -4.41% | -5.56% | -3.18% | -5.30% |
Profit Margin | -0.26% | -0.85% | -4.68% | -4.35% | -6.25% | -4.80% |
Free Cash Flow Margin | 10.62% | 10.09% | 1.29% | -2.01% | 2.51% | -5.64% |
EBITDA | 36.89 | 32.31 | -2.56 | 4.65 | 36.75 | 23.65 |
EBITDA Margin | 1.80% | 1.66% | -0.15% | 0.36% | 2.50% | 8.11% |
D&A For EBITDA | 51.97 | 57.57 | 75.07 | 76.48 | 83.49 | 39.11 |
EBIT | -15.08 | -25.27 | -77.63 | -71.83 | -46.74 | -15.46 |
EBIT Margin | -0.73% | -1.30% | -4.41% | -5.56% | -3.18% | -5.30% |